Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.6 USD | +7.09% | +16.79% | +10.05% |
12:14pm | Morgan Stanley Upgrades PTC Therapeutics to Equalweight From Underweight, Adjusts PT to $30 From $28 | MT |
Apr. 26 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.05% | 2.19B | |
-2.08% | 103B | |
+1.97% | 95.28B | |
+2.85% | 22.15B | |
-15.88% | 21.02B | |
-8.52% | 18.15B | |
-41.01% | 16.73B | |
-14.06% | 16.05B | |
+4.44% | 13.68B | |
+33.36% | 12.17B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- PTC Therapeutics' Muscle Disorder Drug Gets Negative Opinion From European Medicines Agency